Connection

Emil Say to Angiogenesis Inhibitors

Back to Details
This is a "connection" page, showing publications Emil Say has written about Angiogenesis Inhibitors.
Emil Say
Connection Strength
0.109
Angiogenesis Inhibitors
  1. Intravitreal bevacizumab at 4-month intervals for prevention of macular edema after plaque radiotherapy of uveal melanoma. Ophthalmology. 2014 Jan; 121(1):269-275.
    View in: PubMed
    Score: 0.109
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.